Join

Compare · SEER vs WAT

SEER vs WAT

Side-by-side comparison of Seer Inc. (SEER) and Waters Corporation (WAT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both SEER and WAT operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • WAT is the larger of the two at $35.67B, about 362.5x SEER ($98.4M).
  • Over the past year, SEER is down 18.4% and WAT is up 4.2% - WAT leads by 22.5 points.
  • SEER has been more active in the news (17 items in the past 4 weeks vs 8 for WAT).
  • WAT has more recent analyst coverage (25 ratings vs 8 for SEER).
PerformanceSEER-18.37%WAT+4.18%
2025-06-09+0.00%2026-06-08
MetricSEERWAT
Company
Seer Inc.
Waters Corporation
Price
$1.80+0.84%
$363.20-0.59%
Market cap
$98.4M
$35.67B
1M return
-4.51%
+3.68%
1Y return
-18.37%
+4.18%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NYSE
IPO
2020
1995
News (4w)
17
8
Recent ratings
8
25
SEER

Seer Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

WAT

Waters Corporation

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Latest SEER

Latest WAT